A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)
Clinical trial NCT04220411 · TERMINATED
Trial details
- NCT number
- NCT04220411
- Sponsor
- Arjil Pharmaceuticals LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-08
- Primary completion
- 2021-12-29
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.